NCNA logo

NuCana plc American Depositary Share


NCNA: NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.


Show NCNA Financials

Consumer Interest
SEC Filings

Recent trades of NCNA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NCNA's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NCNA in WallStreetBets Daily Discussion


Recent insights relating to NCNA

CNBC Recommendations

Recent picks made for NCNA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NCNA

Corporate Flights

Flights by private jets registered to NCNA